NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 87 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $521,721 | -62.4% | 289,845 | -55.8% | 0.03% | -62.2% |
| Q3 2022 | $1,389,000 | -34.2% | 655,338 | -16.5% | 0.09% | -15.1% |
| Q2 2022 | $2,111,000 | -45.6% | 784,798 | -12.2% | 0.11% | -38.4% |
| Q1 2022 | $3,878,000 | -27.3% | 893,561 | -13.2% | 0.17% | -8.5% |
| Q4 2021 | $5,335,000 | -16.8% | 1,029,872 | -1.4% | 0.19% | -6.9% |
| Q3 2021 | $6,412,000 | -46.7% | 1,044,267 | -12.3% | 0.20% | -40.9% |
| Q2 2021 | $12,027,000 | – | 1,190,810 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
| Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
| ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
| Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
| Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
| Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
| Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |